Latest Ragon Institute Stories
An experimental vaccine tested in rhesus monkeys helped protect them from getting infected with Simian Immunodeficiency Virus (SIV) -- the primate version of HIV and AIDS -- and appears to make the disease more manageable in those who aren’t protected.
BOSTON, and MELBOURNE, Australia, June 7 /PRNewswire/ -- Opal Therapeutics Inc. (Opal) and Massachusetts General Hospital (MGH) have entered into a joint development collaboration agreement to develop a novel immunotherapy to treat HIV.
A new finding from the Ragon Institute of MGH, MIT and Harvard may have implications for designing an effective AIDS vaccine.
- A transitional zone between two communities containing the characteristic species of each.